Stauffer, Frederic, Holzer, Philipp and Garcia-Echeverria, Carlos (2005) Blocking the PI3K/PKB pathway in tumor cells. Current Medicinal Chemistry. Anti-cancer Agents, 5 (5). pp. 449-462. ISSN 1568-0118

Abstract

A substantial number of experimental and epidemiological studies support an important role for the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) pathway in the biology of human cancers. Components of this signaling cascade have been found to be deregulated in a wide range of solid tumors and hematologic malignancies, and extensive anti-cancer therapeutic programs are now devoted to the identification of agents that specifically block this molecular pathway. This article focuses on the current knowledge of the alterations of the PI3K/PKB pathway in cancer cells and ongoing drug discovery efforts to therapeutically target it. Particular emphasis is placed on medicinal chemistry activities to identify and develop compounds able to modulate the kinase activity of its main molecular components.

Item Type:	Article
Related URLs:	http://www.ncbi.nlm.nih.gov/sites/entrez...
Additional Information:	author can archive post-print (ie final draft post-refereeing); Publisher's version/PDF cannot be used
Keywords:	kinase inhibitors; apoptosis; targeted therapy; experimental therapeutics; lipid kinase; serine/threonine kinase; cell survival
Related URLs:	http://www.ncbi.nlm.nih.gov/sites/entrez...
Date Deposited:	14 Dec 2009 13:58
Last Modified:	31 Jan 2013 01:15
URI:	https://oak.novartis.com/id/eprint/507